Place de l'aprotinine en chirurgie cardiaque

Mangano, 2006, The risk associated with aprotinin in cardiac surgery, New Engl J. Med., 354, 353, 10.1056/NEJMoa051379 Fremes, 1994, Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding, Ann Thorac Surg, 58, 1580, 10.1016/0003-4975(94)91636-5 Laupacis, 1997, Drugs to minimize blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome, Anesth Analg, 85, 1258, 10.1213/00000539-199712000-00014 Sedrakyan, 2004, Effect of aprotinin on clinical outcomes in coronary bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials, Journal of Thoracic and Cardiovascular surgery, 128, 442, 10.1016/j.jtcvs.2004.03.041 Henry, 1999, Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001886 Levi, 1999, Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints, Lancet, 354, 1940, 10.1016/S0140-6736(99)01264-7 Weightman, 2001, Pharmacological strategies for blood loss [letter], Lancet, 357, 1131, 10.1016/S0140-6736(00)04283-5 Mangano, 2002, Aspirin and mortality from coronary bypass surgery, N Engl J Med, 347, 1309, 10.1056/NEJMoa020798 Ott, 2003, CABG-surgery in Europe and North America: timelines and outcomes, Anesthesiology, 99, A254